Cadmium in PDB 3q2g: ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors
Protein crystallography data
The structure of ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors, PDB code: 3q2g
was solved by
S.Gerhardt,
D.Hargreaves,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
114.71 /
2.30
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
51.309,
63.419,
114.912,
90.00,
89.88,
90.00
|
R / Rfree (%)
|
20.8 /
26.1
|
Other elements in 3q2g:
The structure of ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors also contains other interesting chemical elements:
Cadmium Binding Sites:
The binding sites of Cadmium atom in the ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors
(pdb code 3q2g). This binding sites where shown within
5.0 Angstroms radius around Cadmium atom.
In total 5 binding sites of Cadmium where determined in the
ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors, PDB code: 3q2g:
Jump to Cadmium binding site number:
1;
2;
3;
4;
5;
Cadmium binding site 1 out
of 5 in 3q2g
Go back to
Cadmium Binding Sites List in 3q2g
Cadmium binding site 1 out
of 5 in the ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 1 of ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cd501
b:38.5
occ:1.00
|
O
|
A:HOH344
|
2.1
|
27.7
|
1.0
|
OD1
|
A:ASP92
|
2.1
|
39.1
|
1.0
|
OD2
|
A:ASP213
|
2.1
|
40.4
|
1.0
|
OE1
|
A:GLU9
|
2.2
|
26.6
|
1.0
|
O
|
A:HOH362
|
2.2
|
47.9
|
1.0
|
O
|
A:ASP92
|
3.0
|
48.4
|
1.0
|
CD
|
A:GLU9
|
3.0
|
29.5
|
1.0
|
OE2
|
A:GLU9
|
3.1
|
32.7
|
1.0
|
CG
|
A:ASP92
|
3.2
|
45.9
|
1.0
|
CG
|
A:ASP213
|
3.2
|
40.0
|
1.0
|
OD1
|
A:ASP213
|
3.7
|
39.7
|
1.0
|
OD2
|
A:ASP92
|
3.9
|
44.3
|
1.0
|
CD
|
A:CD601
|
3.9
|
38.6
|
1.0
|
C
|
A:ASP92
|
4.0
|
48.1
|
1.0
|
O
|
A:HOH356
|
4.1
|
31.8
|
1.0
|
O
|
A:HIS97
|
4.1
|
32.1
|
1.0
|
O
|
A:ASP94
|
4.2
|
45.5
|
1.0
|
CB
|
A:ASP92
|
4.2
|
47.4
|
1.0
|
CA
|
A:ASP92
|
4.4
|
47.5
|
1.0
|
CG
|
A:GLU9
|
4.4
|
28.8
|
1.0
|
CB
|
A:ASP213
|
4.5
|
40.6
|
1.0
|
O
|
A:LYS214
|
4.5
|
41.2
|
1.0
|
O
|
A:HOH352
|
5.0
|
22.4
|
1.0
|
|
Cadmium binding site 2 out
of 5 in 3q2g
Go back to
Cadmium Binding Sites List in 3q2g
Cadmium binding site 2 out
of 5 in the ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 2 of ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cd502
b:66.6
occ:0.50
|
OE1
|
A:GLU68
|
2.3
|
46.2
|
1.0
|
OE1
|
A:GLU63
|
2.9
|
47.9
|
1.0
|
NI
|
A:NI609
|
3.0
|
76.3
|
1.0
|
OE2
|
A:GLU63
|
3.3
|
49.9
|
1.0
|
CD
|
A:GLU63
|
3.4
|
49.0
|
1.0
|
CD
|
A:GLU68
|
3.5
|
43.4
|
1.0
|
OE2
|
A:GLU68
|
4.2
|
44.3
|
1.0
|
CB
|
A:GLU68
|
4.5
|
39.9
|
1.0
|
CG
|
A:GLU68
|
4.6
|
40.8
|
1.0
|
CA
|
A:GLU68
|
4.8
|
39.0
|
1.0
|
CG
|
A:GLU63
|
4.9
|
46.6
|
1.0
|
|
Cadmium binding site 3 out
of 5 in 3q2g
Go back to
Cadmium Binding Sites List in 3q2g
Cadmium binding site 3 out
of 5 in the ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 3 of ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cd601
b:38.6
occ:1.00
|
OD2
|
A:ASP99
|
2.3
|
30.0
|
1.0
|
OD1
|
A:ASP213
|
2.4
|
39.7
|
1.0
|
O
|
A:CYS210
|
2.4
|
34.0
|
1.0
|
O
|
A:HOH352
|
2.4
|
22.4
|
1.0
|
OE1
|
A:GLU9
|
2.6
|
26.6
|
1.0
|
OD1
|
A:ASP99
|
2.6
|
32.8
|
1.0
|
OD2
|
A:ASP92
|
2.8
|
44.3
|
1.0
|
CG
|
A:ASP99
|
2.8
|
29.6
|
1.0
|
CG
|
A:ASP213
|
3.3
|
40.0
|
1.0
|
OD1
|
A:ASP92
|
3.4
|
39.1
|
1.0
|
CG
|
A:ASP92
|
3.5
|
45.9
|
1.0
|
CD
|
A:GLU9
|
3.5
|
29.5
|
1.0
|
C
|
A:CYS210
|
3.6
|
34.5
|
1.0
|
OD2
|
A:ASP213
|
3.6
|
40.4
|
1.0
|
CG
|
A:GLU9
|
3.7
|
28.8
|
1.0
|
CD
|
A:CD501
|
3.9
|
38.5
|
1.0
|
CA
|
A:LEU211
|
4.2
|
34.8
|
1.0
|
CB
|
A:ASP99
|
4.3
|
28.2
|
1.0
|
CB
|
A:GLU9
|
4.3
|
28.7
|
1.0
|
N
|
A:LEU211
|
4.3
|
35.0
|
1.0
|
O
|
A:TYR7
|
4.4
|
32.0
|
1.0
|
O
|
A:ASP213
|
4.6
|
39.3
|
1.0
|
O
|
A:HOH366
|
4.6
|
32.4
|
1.0
|
OE2
|
A:GLU9
|
4.7
|
32.7
|
1.0
|
CA
|
A:CYS210
|
4.7
|
34.5
|
1.0
|
C
|
A:LEU211
|
4.7
|
36.4
|
1.0
|
CB
|
A:ASP213
|
4.7
|
40.6
|
1.0
|
CB
|
A:CYS210
|
4.8
|
33.6
|
1.0
|
N
|
A:ASP213
|
4.9
|
40.5
|
1.0
|
|
Cadmium binding site 4 out
of 5 in 3q2g
Go back to
Cadmium Binding Sites List in 3q2g
Cadmium binding site 4 out
of 5 in the ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 4 of ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cd602
b:44.0
occ:1.00
|
OD1
|
A:ASP231
|
2.3
|
32.6
|
1.0
|
O
|
A:HOH361
|
2.3
|
22.5
|
1.0
|
ND1
|
B:HIS28
|
2.3
|
27.3
|
1.0
|
OD2
|
A:ASP231
|
2.9
|
30.2
|
1.0
|
CG
|
A:ASP231
|
2.9
|
28.2
|
1.0
|
CE1
|
B:HIS28
|
3.2
|
26.4
|
1.0
|
CG
|
B:HIS28
|
3.3
|
25.9
|
1.0
|
CB
|
B:HIS28
|
3.6
|
25.2
|
1.0
|
O
|
A:HOH310
|
4.3
|
41.6
|
1.0
|
CA
|
B:HIS28
|
4.3
|
25.6
|
1.0
|
CB
|
A:ASP231
|
4.3
|
26.9
|
1.0
|
O
|
A:HOH334
|
4.4
|
43.7
|
1.0
|
CG
|
A:ARG234
|
4.4
|
24.3
|
1.0
|
NE2
|
B:HIS28
|
4.4
|
24.7
|
1.0
|
CB
|
A:ASN233
|
4.4
|
25.4
|
1.0
|
CD2
|
B:HIS28
|
4.5
|
24.8
|
1.0
|
ND2
|
A:ASN233
|
4.6
|
26.6
|
1.0
|
CD
|
A:ARG234
|
4.7
|
26.2
|
1.0
|
CG
|
B:PRO222
|
5.0
|
36.6
|
1.0
|
|
Cadmium binding site 5 out
of 5 in 3q2g
Go back to
Cadmium Binding Sites List in 3q2g
Cadmium binding site 5 out
of 5 in the ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors
Mono view
Stereo pair view
|
A full contact list of Cadmium with other atoms in the Cd binding
site number 5 of ADAMTS1 in Complex with A Novel N-Hydroxyformamide Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cd605
b:42.3
occ:1.00
|
OD2
|
B:ASP213
|
2.1
|
47.1
|
1.0
|
OD1
|
B:ASP92
|
2.3
|
52.8
|
1.0
|
OE2
|
B:GLU9
|
2.4
|
36.5
|
1.0
|
OE1
|
B:GLU9
|
2.6
|
38.9
|
1.0
|
CD
|
B:GLU9
|
2.8
|
35.5
|
1.0
|
O
|
B:ASP92
|
3.2
|
56.2
|
1.0
|
CG
|
B:ASP92
|
3.2
|
55.1
|
1.0
|
CG
|
B:ASP213
|
3.2
|
46.5
|
1.0
|
OD2
|
B:ASP92
|
3.7
|
54.1
|
1.0
|
OD1
|
B:ASP213
|
3.9
|
46.9
|
1.0
|
NI
|
B:NI606
|
4.0
|
21.3
|
1.0
|
O
|
B:HOH343
|
4.1
|
39.3
|
1.0
|
O
|
B:ASP94
|
4.2
|
53.0
|
1.0
|
OE1
|
B:GLN216
|
4.2
|
59.7
|
1.0
|
C
|
B:ASP92
|
4.2
|
57.0
|
1.0
|
CB
|
B:ASP213
|
4.3
|
47.3
|
1.0
|
O
|
B:HIS97
|
4.3
|
40.2
|
1.0
|
CG
|
B:GLU9
|
4.3
|
35.0
|
1.0
|
CB
|
B:ASP92
|
4.3
|
56.4
|
1.0
|
O
|
B:LYS214
|
4.4
|
47.3
|
1.0
|
O
|
B:HOH303
|
4.5
|
10.3
|
1.0
|
CA
|
B:ASP92
|
4.6
|
56.9
|
1.0
|
O
|
B:ASP213
|
4.9
|
44.7
|
1.0
|
CB
|
B:HIS97
|
5.0
|
44.7
|
1.0
|
|
Reference:
C.De Savi,
A.Pape,
J.G.Cumming,
A.Ting,
P.D.Smith,
J.N.Burrows,
M.Mills,
C.Davies,
S.Lamont,
D.Milne,
C.Cook,
P.Moore,
Y.Sawyer,
S.Gerhardt.
The Design and Synthesis of Novel N-Hydroxyformamide Inhibitors of Adam-TS4 For the Treatment of Osteoarthritis Bioorg.Med.Chem.Lett. V. 21 1376 2011.
ISSN: ISSN 0960-894X
PubMed: 21300546
DOI: 10.1016/J.BMCL.2011.01.036
Page generated: Fri Jul 19 16:24:04 2024
|